147 related articles for article (PubMed ID: 31511271)
21. Do fundic gland polyps develop under long-term omeprazole therapy?
Declich P; Ferrara A; Galati F; Caruso S; Baldacci MP; Ambrosiani L
Am J Gastroenterol; 1998 Aug; 93(8):1393. PubMed ID: 9707087
[No Abstract] [Full Text] [Related]
22. Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease.
Revicki DA; Sorensen S; Maton PN; Orlando RC
Dig Dis; 1998; 16(5):284-91. PubMed ID: 9892788
[TBL] [Abstract][Full Text] [Related]
23. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
[TBL] [Abstract][Full Text] [Related]
24. Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease.
Armstrong D
Lancet; 2000 Aug; 356(9230):610-2. PubMed ID: 10968429
[No Abstract] [Full Text] [Related]
25. Long-term effects of omeprazole on the gastric mucosa.
Driman DK; Tougas G; Riddell R
Gastroenterology; 2000 Oct; 119(4):1176. PubMed ID: 11203030
[No Abstract] [Full Text] [Related]
26. Fundic gland polyps developing during omeprazole therapy.
el-Zimaity HM; Jackson FW; Graham DY
Am J Gastroenterol; 1997 Oct; 92(10):1858-60. PubMed ID: 9382052
[TBL] [Abstract][Full Text] [Related]
27. Acid suppression therapy in Barrett's esophagus: the importance of pH monitoring.
Castell DO
Curr Gastroenterol Rep; 2000 Jun; 2(3):173-4. PubMed ID: 10957927
[No Abstract] [Full Text] [Related]
28. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
Fitton A; Wiseman L
Drugs; 1996 Mar; 51(3):460-82. PubMed ID: 8882382
[TBL] [Abstract][Full Text] [Related]
29. Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 case reports and review of the literature.
Demirkan K; Bozkurt B; Karakaya G; Kalyoncu AF
J Investig Allergol Clin Immunol; 2006; 16(3):203-9. PubMed ID: 16784015
[TBL] [Abstract][Full Text] [Related]
30. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group.
Wiklund I; Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir D; Fulton C; Gillon K; Peacock R
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):19-27. PubMed ID: 9615259
[TBL] [Abstract][Full Text] [Related]
31. Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease.
Stålhammar NO; Carlsson J; Peacock R; Müller-Lissner S; Bigard MA; Porro GB; Ponce J; Hosie J; Scott M; Weir DG; Fulton C; Gillon K; Bardhan KD
Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):483-97. PubMed ID: 10662395
[TBL] [Abstract][Full Text] [Related]
32. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
Caro JJ; Salas M; Ward A
Clin Ther; 2001 Jul; 23(7):998-1017. PubMed ID: 11519776
[TBL] [Abstract][Full Text] [Related]
33. Cost effectiveness of treatment for gastro-oesophageal reflux.
Laheij RJ; Jansen JB; Severens JL; Verbeek AL
Gut; 1998 Nov; 43(5):728-9; author reply 729-30. PubMed ID: 9917194
[No Abstract] [Full Text] [Related]
34. Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group.
Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir DG; Gillon KR; Peacock RA; Fulton C
BMJ; 1999 Feb; 318(7182):502-7. PubMed ID: 10024259
[TBL] [Abstract][Full Text] [Related]
35. Autoimmune haemolytic anaemia associated with use of omeprazole.
Butt MI; Sajid S; Sobolewski S
Br J Hosp Med (Lond); 2007 Feb; 68(2):108. PubMed ID: 17370722
[No Abstract] [Full Text] [Related]
36. [Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with omeprazole].
Kim JS; Chae HS; Kim HK; Cho YS; Park YW; Son HS; Han SW; Choi KY
Korean J Gastroenterol; 2008 May; 51(5):305-8. PubMed ID: 18516015
[TBL] [Abstract][Full Text] [Related]
37. Patterns of 24-hour oesophageal acid exposure after acute withdrawal of acid suppression.
Orr WC; Mellow MH; Grossman MR
Aliment Pharmacol Ther; 1995 Oct; 9(5):571-4. PubMed ID: 8580280
[TBL] [Abstract][Full Text] [Related]
38. Proton pump inhibitors.
Katelaris PH
Med J Aust; 1998 Aug; 169(4):208-11. PubMed ID: 9734580
[No Abstract] [Full Text] [Related]
39. [Delayed increase of serum gastrin level during prolonged treatment with omeprazole: two cases].
Bardou M; Mallet L; Terris G
Gastroenterol Clin Biol; 1995 May; 19(5):542-3. PubMed ID: 7590009
[No Abstract] [Full Text] [Related]
40. Observation of gastric glandular cysts in the corpus mucosa of the stomach under omeprazole treatment.
Stolte M; Bethke B; Seifert E; Armbrecht U; Lütke A; Goldbrunner P; Rabast U
Z Gastroenterol; 1995 Mar; 33(3):146-9. PubMed ID: 7754645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
